In addition, recent studies suggested that SGLT2 inhibitors can not only regulate glucose metabolism and enhance glucose tolerance by improving insulin resistance (94), but also improve the function of pancreatic beta cells (95). Here, SLC5A2 is linked to Insulin resistance.